An experimental eye implant could be the secret to restoring a patient’s central vision—the part of our eye that lets us see faces, details, and letters more clearly. Many patients now using the implant as part of a clinical trial have reported successful results. The implant was developed by Science Corporation, a competitor to Elon Musk’s Neuralink, which Musk plans to use to merge humans and AI together. The company announced preliminary results for its latest clinical trial this week, reporting that some study participants can now see well enough to read from books, play cards, and more. All of...